0001209191-12-017092.txt : 20120309
0001209191-12-017092.hdr.sgml : 20120309
20120309134124
ACCESSION NUMBER: 0001209191-12-017092
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120301
FILED AS OF DATE: 20120309
DATE AS OF CHANGE: 20120309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Erck Stanley C
CENTRAL INDEX KEY: 0001342826
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 12679966
MAIL ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD, #250
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9920 BELWARD CAMPUS DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 9920 BELWARD CAMPUS DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
doc4.xml
FORM 4 SUBMISSION
X0304
4
2012-03-01
0
0001000694
NOVAVAX INC
NVAX
0001342826
Erck Stanley C
C/O 9920 BELWARD CAMPUS DRIVE
ROCKVILLE
MD
20850
1
1
0
0
President and CEO
Options-right to buy
1.28
2012-03-01
4
A
0
900000
1.28
A
2022-03-01
Common Stock
900000
2070000
D
Options shall vest in four equal annual installments beginning on the first anniversary of the date of grant.
/s/ John Herrmann, Attorney-in-fact for Stanley Erck
2012-03-09